These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10600349)
1. Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. Wang X; Smith P; Pu LL; Kim YJ; Ko F; Robson MC J Surg Res; 1999 Dec; 87(2):194-200. PubMed ID: 10600349 [TBL] [Abstract][Full Text] [Related]
2. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327 [TBL] [Abstract][Full Text] [Related]
4. An in vivo model of human proliferative scar. Polo M; Kim YJ; Kucukcelebi A; Hayward PG; Ko F; Robson MC J Surg Res; 1998 Feb; 74(2):187-95. PubMed ID: 9587359 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Sato M Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413 [TBL] [Abstract][Full Text] [Related]
6. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts. Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895 [TBL] [Abstract][Full Text] [Related]
7. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. Lu L; Saulis AS; Liu WR; Roy NK; Chao JD; Ledbetter S; Mustoe TA J Am Coll Surg; 2005 Sep; 201(3):391-7. PubMed ID: 16125072 [TBL] [Abstract][Full Text] [Related]
8. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling]. Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642 [TBL] [Abstract][Full Text] [Related]
9. [Effect of asiaticoside on the expression of transforming growth factor-beta mRNA and matrix metalloproteinases in hypertrophic scars]. Zhang T; Rong XZ; Yang RH; Li TZ; Xu YB Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):67-70. PubMed ID: 16495179 [TBL] [Abstract][Full Text] [Related]
10. 5-fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase/activator protein-1 activation. Wendling J; Marchand A; Mauviel A; Verrecchia F Mol Pharmacol; 2003 Sep; 64(3):707-13. PubMed ID: 12920208 [TBL] [Abstract][Full Text] [Related]
11. [The experimental study on antisense TGF-beta 1 in inhibiting scar formation in III degree burn wound]. Luo X; Zhao H; Zhang Y Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 Mar; 18(2):89-91. PubMed ID: 12192769 [TBL] [Abstract][Full Text] [Related]
12. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wang J; Jiao H; Stewart TL; Shankowsky HA; Scott PG; Tredget EE Wound Repair Regen; 2007; 15(4):530-9. PubMed ID: 17650097 [TBL] [Abstract][Full Text] [Related]
13. [The influence of transforming growth factor beta 1 (TGF beta 1) on fibroblast proliferation and collagen synthesis]. Lu Y; Luo S; Liu J Zhonghua Shao Shang Za Zhi; 2001 Dec; 17(6):345-7. PubMed ID: 11859611 [TBL] [Abstract][Full Text] [Related]
14. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Fujiwara M; Muragaki Y; Ooshima A Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Joyce NC; Harris DL; Mello DM Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars. Hakvoort T; Altun V; van Zuijlen PP; de Boer WI; van Schadewij WA; van der Kwast TH Eur Cytokine Netw; 2000 Jun; 11(2):233-39. PubMed ID: 10903802 [TBL] [Abstract][Full Text] [Related]
17. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405 [TBL] [Abstract][Full Text] [Related]
18. [Distribution and expression of transforming growth factor beta and their receptors in hypertrophic scar]. Lu L; Chen YL; Zhang QG Zhonghua Shao Shang Za Zhi; 2004 Feb; 20(1):30-3. PubMed ID: 15059449 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]